Bio Pharma Dive
SEPTEMBER 9, 2020
The median CEO of 231 drug companies analyzed by BioPharma Dive earned 50% more last year than in 2017, a leap that far outpaced the more modest pay gains among employees.
Camargo
SEPTEMBER 9, 2020
With smartphones now ubiquitous, interest has increased in digital health solutions such as telemedicine platforms. The post Prescription Digital Therapeutics: When Software Is the Active Ingredient appeared first on Camargo.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
SEPTEMBER 9, 2020
Widening the number of eligible patients could make Intra-Cellular's schizophrenia pill a blockbuster, analysts forecast.
BioPharma Reporter
SEPTEMBER 9, 2020
Two US government agencies are investigating whether Moderna Therapeutics, the biotech company behind one of the leading Covid-19 vaccine candidates, was upfront about government funding in its filed or awarded patents, as required by federal law.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Bio Pharma Dive
SEPTEMBER 9, 2020
Results from two Phase 3 studies put Merck in position to ask for FDA approval of its shot later this year. Pfizer may not be far behind with a rival product.
BioSpace
SEPTEMBER 9, 2020
Merck, known as MSD outside of the U.S. and Canada, announced on Wednesday that it has seen positive results regarding the safety, tolerability and immunogenicity of V114 in two Phase III studies.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Pharma Times
SEPTEMBER 9, 2020
The drug's cost-effectiveness estimate when used in the maintenance setting is uncertain, the Institute has concluded
Bio Pharma Dive
SEPTEMBER 9, 2020
The company claims its test may help avert deaths from cancers that would otherwise kill later on, but will have a tough task convincing doctors and payers of its merit.
BioSpace
SEPTEMBER 9, 2020
In July, the study was paused after another patient experienced neurological issues.
Bio Pharma Dive
SEPTEMBER 9, 2020
The dispute stems from drugmakers deciding to stop giving 340B discounts to contract pharmacies, which many hospitals use.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
BioPharma Reporter
SEPTEMBER 9, 2020
AstraZeneca has paused vaccination in all of its Oxford COVID-19 vaccine candidate trials globally, because of an unexplained illness in one of the trials.
Scienmag
SEPTEMBER 9, 2020
Credit: IIASA Plant and animal species across the world are steadily disappearing due to human activity. A major new IIASA-led study suggests that without ambitious, integrated action combining conservation and restoration efforts with a transformation of the food system, turning the tide of biodiversity by 2050 or earlier will not be possible. Biodiversity – the […].
pharmaphorum
SEPTEMBER 9, 2020
Geneticist Dr Charles Steward has spent his career studying the human genome – but his work became much more personal when his children were diagnosed with severe neurological diseases. Charlie told pharmaphorum how his search for a genetic cause has led him to straddle the divide between scientist and patient advocate. For some people, a job is more than just a job.
Pharma Times
SEPTEMBER 9, 2020
2020's competitions will uphold the highly-respected judging criteria seen in previous years but with virtual processes enabling entrants to compete for a Pharma award from the comfort of their own homes
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
Scienmag
SEPTEMBER 9, 2020
Study of Costa Rican rainforest shows national parks are more resilient than expected Credit: Jeff Fitlow/Rice University HOUSTON – (Sept. 9, 2020) – National parks are safe havens for endangered and threatened species, but an analysis by Rice University data scientists finds parks and protected areas can preserve more than species. In a study published […].
Pharma Times
SEPTEMBER 9, 2020
The move follows a report which found it is not clear that the current programme will be able to drive the progress needed in the timescale available
JAMA Internal Medicine
SEPTEMBER 9, 2020
This randomized clinical trial examines the effect of recombinant human granulocyte colony-stimulating factor on peripheral blood leukocyte and lymphocyte cell counts and clinical improvement in Chinese patients with COVID-19.
Scienmag
SEPTEMBER 9, 2020
Researchers from Aarhus University have developed a tool, ODiNPred, for prediction of the degree of structural order and disorder in proteins, by using machine learning together with experimental NMR data for hundreds of proteins. Credit: Frans Mulder In the last century, Anfinsen showed beyond a doubt that a protein can find its way back to […].
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
The Pharma Data
SEPTEMBER 9, 2020
The Covid-19 pandemic is thought to be responsible for a surge in people applying for healthcare qualifications. The Universities and Colleges Admissions Service (Ucas) has reported a rise in applications among all ages across the UK. A total of 47,320 people applied for nursing degrees by the end of June, a 16% rise on last year. The increase is thought to be down to admiration for the NHS and also people who have lost their jobs and are looking for new careers.
pharmaphorum
SEPTEMBER 9, 2020
Geneticist Dr Charles Steward has spent his career studying the human genome – but his work became much more personal when his children were diagnosed with severe neurological diseases. Charlie told pharmaphorum how his search for a genetic cause has led him to straddle the divide between scientist and patient advocate. For some people, a job is more than just a job.
BioSpace
SEPTEMBER 9, 2020
Whether your controlling co-worker wants to hold onto all of the data for their own use, refuses to compromise with you on key aspects of a project or insists that their separate piece of the project takes precedence over yours, you definitely have a problem on your hands.
pharmaphorum
SEPTEMBER 9, 2020
A company that has developed a digital treatment for pain and anxiety – Belgium-based Oncomfort – has raised €10 million in first-round financing that will be used to fund international growth. Oncomfort has created a platform called Sedakit that provides ‘digital sedation’ – clinical hypnotherapy sessions delivered via a virtual reality headset accompanied by scripts and immersive sounds designed to dissociate patients from their symptoms.
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
Scienmag
SEPTEMBER 9, 2020
Salk researchers made new inroads into understanding how the commonly prescribed drug metformin works in the body Credit: Salk Institute The diabetes drug metformin–derived from a lilac plant that’s been used medicinally for more than a thousand years–has been prescribed to hundreds of millions of people worldwide as the frontline treatment for type 2 diabetes. […].
Outsourcing Pharma
SEPTEMBER 9, 2020
The clinical-stage biotech firm is investigating early efficacy of its Cymerus mesenchymal stem cells for treatment of severe COVID-19 patients.
Scienmag
SEPTEMBER 9, 2020
Credit: © 2020 KAUST Purifying specific protein molecules from complex mixtures will become easier with a simpler way to detect a molecular “tag” commonly used as a handle to grab the proteins. Proteins, comprising many linked amino acid molecules, form the key “workforce” of molecular biology, performing a multitude of chemical tasks, including catalyzing the […].
pharmaphorum
SEPTEMBER 9, 2020
US biotech Insmed has trumpeted updated phase 2 data from its brensocatib, at this week’s virtual European Respiratory Society conference, showing the drug prolonged time to exacerbations caused by the rare lung disease known as non-cystic fibrosis bronchiectasis (NCFBE). The results, also published in the New England Journal of Medicine, showed that brensocatib significantly prolonged time to first pulmonary exacerbation, the primary endpoint, over the 24-week treatment period for both treatmen
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Scienmag
SEPTEMBER 9, 2020
UH project will develop superconducting magnets for fusion systems Credit: University of Houston Despite growing scientific and commercial interest in fusion as an on-demand energy source – producing emissions-free energy through the fusion of hydrogen atoms – significant obstacles remain. A researcher from the University of Houston has joined an effort by the U.S.
BioSpace
SEPTEMBER 9, 2020
Shares of Satsuma Pharmaceuticals plunged nearly 80% in premarket trading after the company revealed its late-stage migraine treatment failed to hit its co-primary endpoints.
Scienmag
SEPTEMBER 9, 2020
Credit: Mordecai, et al. / Lancet Planetary Health All mosquitoes are not created equal. Different species of the flying pest thrive at various temperature ranges and transmit different diseases. From this starting point, a Stanford-led paper for the first time predicts how, when and where in Sub-Saharan Africa malaria will ebb and other mosquito-borne diseases, […].
BioSpace
SEPTEMBER 9, 2020
Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.
Advertisement
The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.
Expert insights. Personalized for you.
361 
Let's personalize your content